Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Net Cash Flow (2016 - 2025)

Rockwell Medical's Net Cash Flow history spans 16 years, with the latest figure at -$2.9 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 187.19% year-over-year to -$2.9 million; the TTM value through Dec 2025 reached -$5.0 million, down 174.07%, while the annual FY2025 figure was -$5.0 million, 174.07% down from the prior year.
  • Net Cash Flow reached -$2.9 million in Q4 2025 per RMTI's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $20.9 million in Q2 2022 to a low of -$17.8 million in Q3 2022.
  • Average Net Cash Flow over 5 years is -$1.9 million, with a median of -$2.1 million recorded in 2023.
  • Peak YoY movement for Net Cash Flow: soared 732.94% in 2022, then plummeted 394.47% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at -$10.1 million in 2021, then soared by 71.53% to -$2.9 million in 2022, then surged by 142.49% to $1.2 million in 2023, then skyrocketed by 171.87% to $3.3 million in 2024, then crashed by 187.19% to -$2.9 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Net Cash Flow are -$2.9 million (Q4 2025), $1.1 million (Q3 2025), and $1.1 million (Q2 2025).